Trial Outcomes & Findings for Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening (NCT NCT06124131)

Results Overview

Completion of colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test as documented in electronic health record within two months of study enrollment

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

Two months

Results posted on

2025-05-04

Participant Flow

Participant milestones

Participant milestones
Measure	Full Financial Incentives $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Overall Study STARTED	25	25
Overall Study COMPLETED	25	25
Overall Study NOT COMPLETED	0	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Full Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot	Total n=50 Participants Total of all reporting groups
Age, Continuous	52.48 Years STANDARD_DEVIATION 6.63 • n=5 Participants	52.32 Years STANDARD_DEVIATION 6.74 • n=7 Participants	52.40 Years STANDARD_DEVIATION 6.61 • n=5 Participants
Sex: Female, Male Female	15 Participants n=5 Participants	20 Participants n=7 Participants	35 Participants n=5 Participants
Sex: Female, Male Male	10 Participants n=5 Participants	5 Participants n=7 Participants	15 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Asian	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	10 Participants n=5 Participants	11 Participants n=7 Participants	21 Participants n=5 Participants
Race (NIH/OMB) White	14 Participants n=5 Participants	14 Participants n=7 Participants	28 Participants n=5 Participants
Race (NIH/OMB) More than one race	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	1 Participants n=5 Participants	0 Participants n=7 Participants	1 Participants n=5 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	1 Participants n=5 Participants	0 Participants n=7 Participants	1 Participants n=5 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	24 Participants n=5 Participants	25 Participants n=7 Participants	49 Participants n=5 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Region of Enrollment United States	25 Participants n=5 Participants	25 Participants n=7 Participants	50 Participants n=5 Participants

PRIMARY outcome

Timeframe: Two months

Completion of colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test as documented in electronic health record within two months of study enrollment

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms	17 Participants	8 Participants

SECONDARY outcome

Timeframe: Two months

Completion of COVID-19 shot as documented in electronic health record within two months of study enrollment

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Difference in Percent of Participants Completing COVID-19 Shot Between Study Arms	1 Participants	0 Participants

SECONDARY outcome

Timeframe: Two months

Completion of flu shot as documented in electronic health record within two months of study enrollment

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Difference in Percent of Participants Completing Flu Shot Between Study Arms	9 Participants	10 Participants

SECONDARY outcome

Timeframe: Two months

Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, \*OR\* flu shot as documented in electronic health record within two months of study enrollment

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Difference in Percent of Participants Completing at Least One of the Following Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot	20 Participants	13 Participants

SECONDARY outcome

Timeframe: Two months

Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, \*AND\* flu shot as documented in electronic health record within two months of study enrollment

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Difference in Percent of Participants Completing All Three Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot	1 Participants	0 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Three months

Population: Overall Number of Participants Analyzed represents all patients who were approached and considered for recruitment.

Number of patients reached for recruitment

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=123 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Number of Patients Reached for Recruitment	107 Participants	—

OTHER_PRE_SPECIFIED outcome

Timeframe: Three months

Population: Overall Number of Participants Analyzed represents all patients who were reached during recruitment

Number of patients assessed for eligibility

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=107 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Number of Patients Assessed for Eligibility	93 Participants	—

OTHER_PRE_SPECIFIED outcome

Timeframe: Three months

Population: Overall Number of Participants Analyzed represents all patients who underwent eligibility screening and were eligible to participate.

Number of patients consented and randomized

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=53 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Number of Patients Consented and Randomized	50 Participants	—

OTHER_PRE_SPECIFIED outcome

Timeframe: Three months

Number of patients who receive the outreach call intervention

Outcome measures

Outcome measures
Measure	Full Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening	Partial Financial Incentives n=25 Participants $50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Number of Patients Who Receive the Outreach Call Intervention	25 Participants	25 Participants

Adverse Events

Full Financial Incentives

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Partial Financial Incentives

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Laura Perry

Tulane University

Phone: 504-988-8906

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place